心血管

订阅

MedSci主页 / 所有栏目 / 心血管

选刊必看：心血管科期刊Top20排名，还有投稿经验可取经！

2022-09-06 网络 网络

关注

在心血管领域，Nature Reviews Cardiology继续占据榜首，近50分可谓遥遥领先。下面我们一起看看排名前20的期刊都有哪些吧。

在心血管领域，Nature Reviews Cardiology继续占据榜首，近50分可谓遥遥领先。下面我们一起看看排名前20的期刊都有哪些吧。

心血管顶流top20期刊
点击刊名查看详情

TOP 1 Nature Reviews Cardiology 点击查看该期刊投稿经验
TOP 2 CIRCULATION 点击查看该期刊投稿经验
TOP 3 EUROPEAN HEART JOURNAL 点击查看该期刊投稿经验
TOP 4 JAMA Cardiology 点击查看该期刊投稿经验
TOP 5 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 点击查看该期刊投稿经验
TOP 6 CIRCULATION RESEARCH 点击查看该期刊投稿经验
TOP 7 EUROPEAN JOURNAL OF HEART FAILURE 点击查看该期刊投稿经验
TOP 8 CURRENT PROBLEMS IN CARDIOLOGY 点击查看该期刊投稿经验
TOP 9 JACC-Cardiovascular Imaging 点击查看该期刊投稿经验
TOP 10 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 点击查看该期刊投稿经验
TOP 11 PROGRESS IN LIPID RESEARCH 点击查看该期刊投稿经验
TOP 12 JOURNAL OF HEART AND LUNG TRANSPLANTATION 点击查看该期刊投稿经验
TOP 13 CARDIOVASCULAR RESEARCH 点击查看该期刊投稿经验
TOP 14 JACC-Heart Failure 点击查看该期刊投稿经验
TOP 15 BASIC RESEARCH IN CARDIOLOGY 点击查看该期刊投稿经验
TOP 16 PROGRESS IN CARDIOVASCULAR DISEASES 点击查看该期刊投稿经验
TOP 17 European Heart Journal-Cardiovascular Pharmacotherapy 点击查看该期刊投稿经验
TOP 18 JACC-Cardiovascular Interventions 点击查看该期刊投稿经验
TOP 19 ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 点击查看该期刊投稿经验
TOP 20 Circulation-Heart Failure 点击查看该期刊投稿经验

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2115874, encodeId=2b4621158e411, content=马克, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e366482033, createdName=ms9000000298718609, createdTime=Wed Feb 22 10:09:56 CST 2023, time=2023-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054733, encodeId=df9a2054e33cc, content=<a href='/topic/show?id=43f91e650d5' target=_blank style='color:#2F92EE;'>#TOP20#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17650, encryptionId=43f91e650d5, topicName=TOP20)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77b32500129, createdName=12498aa2m62(暂无昵称), createdTime=Fri Jul 07 14:59:29 CST 2023, time=2023-07-07, status=1, ipAttribution=)]
    2023-02-22 ms9000000298718609

    马克

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2115874, encodeId=2b4621158e411, content=马克, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e366482033, createdName=ms9000000298718609, createdTime=Wed Feb 22 10:09:56 CST 2023, time=2023-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054733, encodeId=df9a2054e33cc, content=<a href='/topic/show?id=43f91e650d5' target=_blank style='color:#2F92EE;'>#TOP20#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17650, encryptionId=43f91e650d5, topicName=TOP20)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77b32500129, createdName=12498aa2m62(暂无昵称), createdTime=Fri Jul 07 14:59:29 CST 2023, time=2023-07-07, status=1, ipAttribution=)]
    2023-07-07 12498aa2m62(暂无昵称)

    #TOP20#

    0